Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-17-000971
Filing Date
2017-03-24
Accepted
2017-03-24 16:30:23
Documents
8
Period of Report
2017-05-09
Effectiveness Date
2017-03-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT geron3183221-def14a.htm DEF 14A 846820
2 GRAPHIC geron3183221-def14a1x1.jpg GRAPHIC 4449
3 GRAPHIC geron3183221-def14a1x2.jpg GRAPHIC 11708
4 GRAPHIC geron3183221-def14a3x1.jpg GRAPHIC 4449
5 GRAPHIC geron3183221-def14a3x2.jpg GRAPHIC 8847
6 GRAPHIC geron3183221-def14a66x1.jpg GRAPHIC 10575
7 GRAPHIC geron3183221-def14a67x1.jpg GRAPHIC 15577
8 GRAPHIC geron3183221-def14ax1.jpg GRAPHIC 4468
  Complete submission text file 0001206774-17-000971.txt   931848
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-20859 | Film No.: 17713092
SIC: 2834 Pharmaceutical Preparations